Literature DB >> 26678453

Multimodality Imaging of Ethiodized Oil-loaded Radiopaque Microspheres during Transarterial Embolization of Rabbits with VX2 Liver Tumors.

Vania Tacher1, Rafael Duran1, MingDe Lin1, Jae Ho Sohn1, Karun V Sharma1, Zhijun Wang1, Julius Chapiro1, Carmen Gacchina Johnson1, Nikhil Bhagat1, Matthew R Dreher1, Dirk Schäfer1, David L Woods1, Andrew L Lewis1, Yiqing Tang1, Michael Grass1, Bradford J Wood1, Jean-François Geschwind1.   

Abstract

Purpose To assess the visibility of radiopaque microspheres during transarterial embolization (TAE) in the VX2 rabbit liver tumor model by using multimodality imaging, including single-snapshot radiography, cone-beam computed tomography (CT), multidetector CT, and micro-CT. Materials and Methods The study was approved by the institutional animal care and use committee. Fifteen VX2-tumor-bearing rabbits were assigned to three groups depending on the type of embolic agent injected: 70-150-μm radiopaque microspheres in saline (radiopaque microsphere group), 70-150-μm radiopaque microspheres in contrast material (radiopaque microsphere plus contrast material group), and 70-150-μm radiolucent microspheres in contrast material (nonradiopaque microsphere plus contrast material group). Rabbits were imaged with single-snapshot radiography, cone-beam CT, and multidetector CT. Three to 5 weeks after sacrifice, excised livers were imaged with micro-CT and histologic analysis was performed. The visibility of the embolic agent was assessed with all modalities before and after embolization by using a qualitative three-point scale score reading study and a quantitative assessment of the signal-to-noise ratio (SNR) change in various regions of interest, including the tumor and its feeding arteries. The Kruskal-Wallis test was used to compare the rabbit characteristics across groups, and the Wilcoxon signed rank test was used to compare SNR measurements before and after embolization. Results Radiopaque microspheres were qualitatively visualized within tumor feeding arteries and targeted tissue with all imaging modalities (P < .05), and their presence was confirmed with histologic examination. SNRs of radiopaque microsphere deposition increased after TAE on multidetector CT, cone-beam CT, and micro-CT images (P < .05). Similar results were obtained when contrast material was added to radiopaque microspheres, except for additional image attenuation due to tumor enhancement. For the group with nonradiopaque microspheres and contrast material, retained tumoral contrast remained qualitatively visible with all modalities except for micro-CT, which demonstrated soluble contrast material washout over time. Conclusion Radiopaque microspheres were visible with all imaging modalities and helped increase conspicuity of the tumor as well as its feeding arteries after TAE in a rabbit VX2 liver tumor model. (©) RSNA, 2015.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26678453      PMCID: PMC4886703          DOI: 10.1148/radiol.2015141624

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  31 in total

1.  Estimating the world cancer burden: Globocan 2000.

Authors:  D M Parkin; F Bray; J Ferlay; P Pisani
Journal:  Int J Cancer       Date:  2001-10-15       Impact factor: 7.396

2.  Comparative study between doxorubicin-eluting beads and conventional transarterial chemoembolization for treatment of hepatocellular carcinoma.

Authors:  Myeong Jun Song; Ho Jong Chun; Do Seon Song; Hee Yeon Kim; Sun Hong Yoo; Chung-Hwa Park; Si Hyun Bae; Jong Young Choi; U Im Chang; Jin Mo Yang; Hae Giu Lee; Seung Kew Yoon
Journal:  J Hepatol       Date:  2012-07-20       Impact factor: 25.083

3.  Liver, gastrointestinal, and cardiac toxicity in intermediate hepatocellular carcinoma treated with PRECISION TACE with drug-eluting beads: results from the PRECISION V randomized trial.

Authors:  Thomas J Vogl; Johannes Lammer; Riccardo Lencioni; Katerina Malagari; Anthony Watkinson; Frank Pilleul; Alban Denys; Clara Lee
Journal:  AJR Am J Roentgenol       Date:  2011-10       Impact factor: 3.959

4.  New insights into the mechanisms of the interactions between doxorubicin and the ion-exchange hydrogel DC Bead™ for use in transarterial chemoembolization (TACE).

Authors:  Marco Biondi; Sabato Fusco; Andrew L Lewis; Paolo A Netti
Journal:  J Biomater Sci Polym Ed       Date:  2011-01-21       Impact factor: 3.517

5.  Radiopaque drug-eluting beads for transcatheter embolotherapy: experimental study of drug penetration and coverage in swine.

Authors:  Matthew R Dreher; Karun V Sharma; David L Woods; Goutham Reddy; Yiqing Tang; William F Pritchard; Oscar A Chiesa; John W Karanian; Juan A Esparza; Danielle Donahue; Elliot B Levy; Sean L Willis; Andrew L Lewis; Bradford J Wood
Journal:  J Vasc Interv Radiol       Date:  2011-12-16       Impact factor: 3.464

6.  Hydrogels in endovascular embolization. VI. Toxicity tests of poly(2-hydroxyethyl methacrylate) particles on cell cultures.

Authors:  D Horák; M Cervinka; V Půza
Journal:  Biomaterials       Date:  1997-10       Impact factor: 12.479

Review 7.  Transarterial chemoembolization for unresectable hepatocellular carcinoma: meta-analysis of randomized controlled trials.

Authors:  Calogero Cammà; Filippo Schepis; Ambrogio Orlando; Maddalena Albanese; Lillian Shahied; Franco Trevisani; Pietro Andreone; Antonio Craxì; Mario Cottone
Journal:  Radiology       Date:  2002-07       Impact factor: 11.105

Review 8.  The Barcelona approach: diagnosis, staging, and treatment of hepatocellular carcinoma.

Authors:  Josep M Llovet; Josep Fuster; Jordi Bruix
Journal:  Liver Transpl       Date:  2004-02       Impact factor: 5.799

9.  Multimodal visibility of a modified polyzene-F-coated spherical embolic agent for liver embolization: feasibility study in a porcine model.

Authors:  Ulrike Stampfl; Christof-Matthias Sommer; Nadine Bellemann; Maria Holzschuh; Alexander Kueller; Jacques Bluemmel; Tobias Gehrig; Maxim Shevchenko; Hannes Kenngott; Hans-Ulrich Kauczor; Boris Radeleff
Journal:  J Vasc Interv Radiol       Date:  2012-07-24       Impact factor: 3.464

10.  Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study.

Authors:  Johannes Lammer; Katarina Malagari; Thomas Vogl; Frank Pilleul; Alban Denys; Anthony Watkinson; Michael Pitton; Geraldine Sergent; Thomas Pfammatter; Sylvain Terraz; Yves Benhamou; Yves Avajon; Thomas Gruenberger; Maria Pomoni; Herbert Langenberger; Marcus Schuchmann; Jerome Dumortier; Christian Mueller; Patrick Chevallier; Riccardo Lencioni
Journal:  Cardiovasc Intervent Radiol       Date:  2009-11-12       Impact factor: 2.740

View more
  6 in total

Review 1.  Bench-to-clinic development of imageable drug-eluting embolization beads: finding the balance.

Authors:  Andrew L Lewis; Sean L Willis; Matthew R Dreher; Yiqing Tang; Koorosh Ashrafi; Bradford J Wood; Elliot B Levy; Karun V Sharma; Ayele H Negussie; Andrew S Mikhail
Journal:  Future Oncol       Date:  2018-06-26       Impact factor: 3.404

2.  Distribution and Detection of Radiopaque Beads after Hepatic Transarterial Embolization in Swine: Cone-Beam CT versus MicroCT.

Authors:  John G Thompson; William van der Sterren; Ivane Bakhutashvili; Imramsjah M van der Bom; Alessandro G Radaelli; John W Karanian; Juan Esparza-Trujillo; David L Woods; Andrew L Lewis; Bradford J Wood; William F Pritchard
Journal:  J Vasc Interv Radiol       Date:  2018-03-02       Impact factor: 3.464

3.  First Human Experience with Directly Image-able Iodinated Embolization Microbeads.

Authors:  Elliot B Levy; Venkatesh P Krishnasamy; Andrew L Lewis; Sean Willis; Chelsea Macfarlane; Victoria Anderson; Imramsjah Mj van der Bom; Alessandro Radaelli; Matthew R Dreher; Karun V Sharma; Ayele Negussie; Andrew S Mikhail; Jean-Francois H Geschwind; Bradford J Wood
Journal:  Cardiovasc Intervent Radiol       Date:  2016-05-20       Impact factor: 2.740

4.  Computed tomography and histopathological findings after embolization with inherently radiopaque 40μm-microspheres, standard 40μm-microspheres and iodized oil in a porcine liver model.

Authors:  Dominik F Vollherbst; Theresa Gockner; Thuy Do; Kerstin Holzer; Carolin Mogler; Paul Flechsig; Alexander Harms; Christopher L Schlett; Philippe L Pereira; Götz M Richter; Hans U Kauczor; Christof M Sommer
Journal:  PLoS One       Date:  2018-07-09       Impact factor: 3.240

5.  Microfluidic-prepared, monodisperse, X-ray-visible, embolic microspheres for non-oncological embolization applications.

Authors:  Cyrus W Beh; Yingli Fu; Clifford R Weiss; Charles Hu; Aravind Arepally; Hai-Quan Mao; Tza-Huei Wang; Dara L Kraitchman
Journal:  Lab Chip       Date:  2020-09-01       Impact factor: 6.799

6.  131I-Labeled Copper Sulfide-Loaded Microspheres to Treat Hepatic Tumors via Hepatic Artery Embolization.

Authors:  Qiufang Liu; Yuyi Qian; Panli Li; Sihang Zhang; Jianjun Liu; Xiaoguang Sun; Michael Fulham; Dagan Feng; Gang Huang; Wei Lu; Shaoli Song
Journal:  Theranostics       Date:  2018-01-01       Impact factor: 11.556

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.